JIANPING ZHOU: Open Payments
NPI 1881636744 · PASADENA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 34 payments from 15 companies in 2025. Trend: 2023 $992 · 2024 $1,208 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $280 |
| ABBVIE INC. | 6 | $175 |
| Corcept Therapeutics | 2 | $137 |
| Dexcom, Inc. | 2 | $126 |
| Lilly USA, LLC | 2 | $123 |
| Axsome Therapeutics, Inc. | 1 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| Exact Sciences Corporation | 2 | $42 |
| PFIZER INC. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $30 |
Products named: Korlym, QULIPTA, ZEPBOUND, DEXCOM G7 GSS (161), Auvelity, JARDIANCE, VRAYLAR, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
